Table 2. Clinical Rcsponse
Patient |
Mean Lightening* (5.0-mm spot size) |
Mean Lightening* (6.5-tnm spot size) |
Complications |
1 |
3.00 |
3.25 |
Nonę |
2 |
2.50 |
2.50 |
Hypertrophy, change in colorł |
3 |
1.75 |
2.25 |
Nonę |
2.00 |
2.25 |
Nonę | |
4 |
1.00 |
1.00 |
Hyperpigmentation, |
5 |
2.00 |
1.50 |
Nonę |
6 |
2.75 |
2.75 |
Nonę |
7 |
2.25 |
2.25 |
Nonę |
8 |
2.25 |
2.25 |
Nonę |
9 |
1.00 |
2.00 |
Hyperpigmentationł |
10 |
2.25 |
2.00 |
Nonę |
11 |
1.25 |
1.50 |
Nonę |
* Mean lightening as nwluated by four imymtigators: 7 (0-25%); 2 (26-50%); 3 (51-75%); 4 (76-100%). t Complications dcveloped itt bo!h treatment halves. |